See a Demo

Category: Blog

TrialAssure cubes divider
TrialAssure and Cancer Research UK Collaborate

TrialAssure and Cancer Research UK Collaborate to Advance AI-Supported Regulatory Document Authoring

by Don McLean | June 2026

Posted in Blog, News
Read More
Dr. Oladayo Oyelola

Dr. Oladayo Oyelola Joins TrialAssure’s Advisory Board to Support Clinical Trial Transparency Strategy

by Don McLean | June 2026

Posted in Blog, News
Read More
Pill with DNA Strand

What AI Drug Discovery Can Teach Us About Responsible AI Across the Clinical Development Pipeline

by Staff Writer | June 2026

Posted in Blog
Read More
Helping Medical Writers Embrace AI Through Effective Change Management Artificial intelligence (AI) is rapidly changing the way clinical and regulatory content is developed across the pharmaceutical and biotechnology industry. The AI medical writing market alone is expected to surpass USD 1.7B by the year 2030, according to Grand View Research, and tools like TrialAssure LINK AI are helping organizations accelerate content generation, support consistency, reduce repetitive work, and improve collaboration across teams. At the same time, introducing AI into medical writing workflows can create understandable concerns among writers, reviewers, and cross-functional stakeholders. Questions around quality, compliance, authorship, job security, and trust naturally arise when new technology becomes part of the highly regulated drug development space. For organizations adopting AI-enabled medical writing platforms, success depends on more implementing and embracing software. To do this, it requires thoughtful change management centered around the people who will use these AI medical writing systems every day. “It’s important that medical writers should feel empowered, respected, and included throughout the transition,” shared James Greene, Executive Director of Growth & Partnerships at TrialAssure. “Companies that approach AI adoption collaboratively are far more likely to see strong engagement, faster adoption, and long-term success.”

Helping Medical Writers Embrace AI Through Effective Change Management

by Don McLean | May 2026

Posted in Blog
Read More

Pharma AI Expert Zach Weingarden of TrialAssure Named a 2026 Crain’s Detroit Business Notable Leader in Health Care

by Don McLean | May 2026

Posted in Blog, News
Read More
Modernizing Federal Technology for a More Connected and Efficient Government | TrialAssure | missing clinical trial results FDA

FDA Flags Thousands of Missing Clinical Trial Results. Is Your Team Prepared?

by Don McLean | April 2026

Posted in Blog
Read More
TrialAssure Wins “Data Privacy Solution of the Year” for AI-Powered Anonymization and Redaction Platform CANTON, Mich. (April 16, 2026) – TrialAssure, a leading technology provider advancing clinical trial transparency, disclosure, and data sharing, announced today that its TrialAssure ANONYMIZE product has been named Data Privacy Solution of the Year in the 2026 Data Breakthrough Awards program. TrialAssure ANONYMIZE supports data sharing and transparency initiatives by automatically identifying sensitive information, applying consistent anonymization rules, and providing full auditability for the pharmaceutical and biotechnology industry. | TrialAssure Wins Prestigious MichBusiness Triple Trusted Advisors Award for its Innovative AI Solutions

TrialAssure Wins “Data Privacy Solution of the Year” for AI-Powered Anonymization and Redaction Platform 

by Staff Writer | April 2026

Posted in Blog, News
Read More
The following case study is based on real work conducted between TrialAssure, MMS, and a top 10 pharma sponsor to accelerate the development of Clinical Study Reports using TrialAssure LINK AI. Problem A top 10 global pharma company launched a challenge to evaluate AI-augmented medical writing for Draft 1 Clinical Study Reports (CSRs). The AI system was required to operate fully within the sponsor’s secure cloud environment and integrate with its proprietary Large Language Model (LLM) under strict governance requirements. The timeline was compressed. After receiving protocols, SAPs, and an extensive list of TLFs, the team had a narrow window to generate both a Draft 1 CSR and Plain Language Summary (PLS). The challenge demanded an unprecedented level of speed and technical precision, with just three (3) days to set up the technical environment and five (5) days to complete the actual document drafts. Solution Using its AI-assisted authoring platform, LINK AI, TrialAssure was selected as one of just a few providers to participate in this program, partnering with MMS, a data-focused CRO, to rapidly deploy the solution within the sponsor’s cloud environment. The team seamlessly integrated the platform with the sponsor’s approved LLMs, configured a structured, AI-driven workflow, and securely ingested sponsor-provided source documents within an accelerated implementation timeline. Our medical writers accessed the sponsor environment to review outputs, refine prompts in real time, and strengthen complex results sections. The team integrated PLS development into the same workflow and produced English, French, and German versions. Then, our technical team addressed deployment and model integration challenges quickly, combining AI acceleration with experienced human oversight. “The team brought strong technical knowledge and medical writing experience together in a way that felt seamless. We were impressed by how responsive the team was, and the improvements made over a short period gave us confidence in its long-term potential.” Results The team successfully delivered a full Draft 1 CSR and PLSs in three (3) languages within just 24 hours of receiving source documents. Additionally, we were able to: Strengthen and expand the CSR template and prompt library. Provide rapid output improvements within mere days. Prove the successful deployment inside a controlled enterprise environment. Position a clear pathway for future enterprise AI-assisted medical writing initiatives. This challenge demonstrated that AI-augmented medical writing with TrialAssure’s LINK AI can function effectively within the strict infrastructure of any pharmaceutical and biotech organization.

Accelerating AI-Augmented CSR Development for a Top Global Biopharma Sponsor

by Staff Writer | April 2026

Posted in Blog, Case Studies
Read More
AI for Medical Writing Certification (AIMWC) Program

AI in Medical Writing Certification Program Launched by TrialAssure to Support Greater Adoption Across Pharma and Biotech

by Staff Writer | March 2026

Posted in Blog, News
Read More
Austin TX

TrialAssure to Lead Discussions on CCI and Smart Anonymization at PHUSE US Connect 2026 in Austin

by Staff Writer | February 2026

Posted in Blog, News
Read More
Get in Touch

Looking to streamline your clinical trial disclosure and transparency efforts?

TrialAssure is ready to help your organization embark on a Transparency Transformation!

To learn more about the TrialAssure Transparency Suite, specific products, or our company, contact us below.

Yes, please send me more information about TrialAssure.